1. Home
  2. REFI vs SOPH Comparison

REFI vs SOPH Comparison

Compare REFI & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFI
  • SOPH
  • Stock Information
  • Founded
  • REFI 2021
  • SOPH 2011
  • Country
  • REFI United States
  • SOPH Switzerland
  • Employees
  • REFI N/A
  • SOPH N/A
  • Industry
  • REFI Real Estate Investment Trusts
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • REFI Real Estate
  • SOPH Health Care
  • Exchange
  • REFI Nasdaq
  • SOPH Nasdaq
  • Market Cap
  • REFI 298.7M
  • SOPH 309.2M
  • IPO Year
  • REFI 2021
  • SOPH 2021
  • Fundamental
  • Price
  • REFI $16.02
  • SOPH $4.58
  • Analyst Decision
  • REFI Buy
  • SOPH Strong Buy
  • Analyst Count
  • REFI 4
  • SOPH 3
  • Target Price
  • REFI $17.33
  • SOPH $7.33
  • AVG Volume (30 Days)
  • REFI 114.5K
  • SOPH 66.1K
  • Earning Date
  • REFI 08-07-2024
  • SOPH 08-06-2024
  • Dividend Yield
  • REFI 11.67%
  • SOPH N/A
  • EPS Growth
  • REFI 0.51
  • SOPH N/A
  • EPS
  • REFI 1.99
  • SOPH N/A
  • Revenue
  • REFI $55,477,705.00
  • SOPH $64,184,000.00
  • Revenue This Year
  • REFI $15.73
  • SOPH $28.97
  • Revenue Next Year
  • REFI $7.11
  • SOPH $28.39
  • P/E Ratio
  • REFI $8.09
  • SOPH N/A
  • Revenue Growth
  • REFI 2.73
  • SOPH 26.68
  • 52 Week Low
  • REFI $13.86
  • SOPH $2.13
  • 52 Week High
  • REFI $17.65
  • SOPH $7.37
  • Technical
  • Relative Strength Index (RSI)
  • REFI 58.46
  • SOPH 45.34
  • Support Level
  • REFI $15.17
  • SOPH $4.48
  • Resistance Level
  • REFI $16.47
  • SOPH $4.81
  • Average True Range (ATR)
  • REFI 0.28
  • SOPH 0.20
  • MACD
  • REFI 0.09
  • SOPH 0.01
  • Stochastic Oscillator
  • REFI 69.80
  • SOPH 54.52

About REFI Chicago Atlantic Real Estate Finance Inc.

Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: